hotspot -WSS

hotspot

author：focus 2025-08-12 11:28:17 - browse：67726

Are biotech’s dog days over? What’s a PIPE? And what can unseat Wegovy?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We dive into the the latest craze in the world of biotech finance, involving hedge funds and some insider information, and explain why not everyone thinks it’s such a good idea. We also discuss a banner month for biotech stocks and the latest twist in obesity research.

For more on what we cover, here’s more on PIPEs; here’s the news from Viking Therapeutics; here’s the latest in MASH; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： To avoid data mishandling cases, universities eye AI and other tools

focus

Wikipedia

WSS

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

Private equity deals in Medicare Advantage declines

The Readout: Gilead, Bernie Sanders, and other pharma news

Senators start work on Medicare physician payment reform

The Readout: Gilead, Bernie Sanders, and other pharma news

How Vertex's cystic fibrosis drug is changing patients' lives

focus

hotspot

focus

In Memoriam: Notable people who died in 2023

Thermo Fisher plant for manufacturing gene therapies to expand

Novavax promises a turnaround & Lilly roils the obesity market

What Congress can do to address the rural doctor shortage

Dobbs anniversary: the lost opportunity of abortion as health care

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

United colonoscopy coverage change 'may cost lives,' doctors say

Industry veterans launch new biotech VC with $310M

Medicare details structure of new drug price negotiation program

CDC's new outbreak response network to include Northeastern

Wikipedia

Biotech lab space demand falls sharply

Medicare Advantage proposed rates disappoint insurers

For Medicare Advantage, Democrats want stronger protections around AI

Senators: Long

Medicare Advantage proposed rates disappoint insurers

STAT Virtual Event: Putting AI to the Test

focus

Wikipedia

knowledge

entertainment